共 7 条
[2]
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study[J] . Yining Huang,Yan Cheng,Jiang Wu,Yansheng Li,En Xu,Zhen Hong,Zhengyi Li,Weiwei Zhang,Meiping Ding,Xuguang Gao,Dongsheng Fan,Jinsheng Zeng,Kasing Wong,Chuanzhen Lu,Jiangxi Xiao,Chen Yao.Lancet Neurology . 2008 (6)
[3]
Modified-release dipyridamole combined with aspirin for secondary stroke prevention[J] . Hans-Christoph Diener.Aging Health . 2005 (1)
[4]
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial[J] . Hans-Christoph Diener,Julien Bogousslavsky,Lawrence M Brass,Claudio Cimminiello,Laszlo Csiba,Markku Kaste,Didier Leys,Jordi Matias-Guiu,Hans-Jürgen Rupprecht.The Lancet . 2004 (9431)
[5]
Aspirin resistance: May be a cause of recurrent ischaemic vascular events in patients taking aspirin[J] . Graeme J Hankey,John W Eikelboom.BMJ: British Medical Journal . 2004 (7438)
[6]
Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction[J] . Fumio Gotoh,Hideo Tohgi,Shunsaku Hirai,Akiro Terashi,Yasuo Fukuuchi,Eiichi Otomo,Yukito Shinohara,Eiichi Itoh,Tamotsu Matsuda,Tohru Sawada,Takenori Yamaguchi,Katsuya Nishimaru,Yasuo Ohashi.Journal of Stroke and Cerebrovascular Diseases . 2000 (4)
[7]
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J] . The Lancet . 1996 (9038)